期刊文献+

原发性胆汁性肝硬化失代偿期多层螺旋CT表现 被引量:3

Multi-slice CT findings of primary biliary cirrhosis
在线阅读 下载PDF
导出
摘要 目的探讨原发性胆汁性肝硬化(PBC)失代偿期的多层螺旋CT(MSCT)影像表现。方法回顾性分析2008年2月~2010年1月临床确诊的24例原发性胆汁性肝硬化失代偿期患者MSCT影像资料,同时选取30例乙肝肝硬化失代偿期患者作为对照组。对2组患者分别进行肝脏体积测量、腹腔淋巴结、侧支循环和胆囊病变的分析。结果 PBC组出现腹腔淋巴结增大为25.0%,对照组16.7%,PBC组高于对照组,有统计学意义(x2=18.555,P<0.01)。PBC组胆囊炎为70.8%,对照组20.0%,PBC组高于对照组,有统计学意义(x2=14.091,P<0.01)。肝脏体积改变及侧支循环与对照组的差异无统计学意义。结论相对于乙肝肝硬化失代偿期,MSCT显示PBC的腹腔淋巴结增大和胆囊炎更为常见。 Objective To retrospectively analyse the multi-slice CT (MSCT) images obtained in patients with primary biliary cirrhosis (PBC). Methods Between February 2008 and January 2010, 24 patients with PBC and 30 subjects with hepatitis B-induced cirrhosis (control group) were performed routine abdominal MSCT. Liver volume measuring, abdomi- nal lymph notes, collateral circulation and gallbladder disease were analyzed in that two group's patients. Results In our study, CT evidence of lymphodenopathy was found in 75.0% and 16.7% of patients in PBC and in hepatitis B-induced cir- rhosis, respectively. Cholecystitis was seen in 70.8% and 20.0% of patients in PBC and in control group, respectively. The lymphodenopathy and cholecystitis were more common in PBC than in control group and there were significant differ- ence between the two groups (X2 = 18. 555, P d0.01 and X2 = 14. 091, P d0.01). The liver volume change and collateral circulation in two groups were not statistically significant ( P 〉0.05). Conclusion The lymphodenopathy and cholecysti- tis are more frequent MSCT findings in primary biliary cirrhosis than that in hepatitis B-induced cirrhosis. The liver vol- ume change and collateral circulation in PBC are similar to that in the control group.
出处 《医学影像学杂志》 2013年第2期237-240,共4页 Journal of Medical Imaging
关键词 肝硬化 胆汁性 体层摄影术 X线计算机 Liver cirrhosis, biliary Tomography, X-ray computed
作者简介 张瑞池(1975-),男,北京市人,本科学历,主治医师,主要从事腹部影像诊断及研究工作 通讯作者:赵大伟主任医师E-mail:zdw2345@yahoo.com.
  • 相关文献

参考文献3

二级参考文献219

  • 1姚定康,谢渭芬,陈伟忠,刘海英,屠小卿,范丽英.抗线粒体抗体及其分型对原发性胆汁性肝硬化的诊断价值[J].中华肝脏病杂志,2005,13(1):9-11. 被引量:42
  • 2Heathcote EJ. Management of primary biliary cirrhosis. The American association for the study of liver diseases practice guidelines. Hepatology, 2000, 31: 1005-1013.
  • 3Talwalkar JA, Lindor KD. Primary biliary cirrhosis. Lancet, 2003, 362: 53-61.
  • 4Talwalkar JA, Gossard AA. Practice variation in treatment of primary biliary cirrhosis and effect on clinical outcomes. Hepatology, 2008, 47: 1428.
  • 5Masuda J, Omagarik, Matsuo I, et al. Changes in titers of antimitochondrial and antinuclear antibodies duringthe course of primary biliary cirrhosis. J Gastroenterol Hepatol, 2001, 16: 239- 243.
  • 6Czaja A J, Carpenter HA, Santrach PJ, et al. Autoimmune cholangitis within the spectrum of autoimmune liver disease. Hepatology, 2000, 31: 1231-1238.
  • 7[177]Sharma A,Provenzale D,McKusick A,Kaplan MM.Interstitial pneumonitis after low-dose methotrexate therapy in primary biliary cirrhosis.Gastroenterology 1994;107:266-270
  • 8[178]Combes B,Emerson SS,Flye NL,Munoz SJ,Luketic VA,Mayo MJ,McCashland TM,Zetterman RK,Peters MG,Di Bisceglie AM,Benner KG,Kowdley KV,Carithers RL Jr,Rosoff L Jr,Garcia-Tsao G,Boyer JL,Boyer TD,Martinez EJ,Bass NM,Lake JR,Barnes DS,Bonacini M,Lindsay KL,Mills AS,Markin RS,Rubin R,West AB,Wheeler DE,Contos MJ,Hofmann AF.Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis.Hepatology 2005;42:1184-1193
  • 9[179]Gonzalez-Koch A,Brahm J,Antezana C,Smok G,Cumsille MA.The combination of ursodeoxycholic acid and methotrexate for primary biliary cirrhosis is not better than ursodeoxycholic acid alone.J Hepatol 1997;27:143-149
  • 10[180]Hendrickse MT,Rigney E,Giaffer MH,Soomro I,Triger DR,Underwood JC,Gleeson D.Low-dose methotrexate is ineffective in primary biliary cirrhosis:long-term results of a placebo-controlled trial.Gastroenterology 1999;117:400-407

共引文献14049

同被引文献34

  • 1Jin-Ping Li,De-Li Zhao,Hui-Jie Jiang,Ya-Hua Huang,Da-Qing Li,Yong Wan, Xin-Ding Liu and Jin-E Wang Department of Radiology,Second Affiliated Hospital,Harbin Medical University,Harbin150086,China.Assessment of tumor vascularization with functional computed tomography perfusion imaging in patients with cirrhotic liver disease[J].Hepatobiliary & Pancreatic Diseases International,2011,10(1):43-49. 被引量:21
  • 2马春梅,郭启勇,廖伟,郭文力,于涛,冯国强.CT灌注成像在兔肝纤维化模型的研究[J].中国医学影像技术,2007,23(5):641-644. 被引量:23
  • 3隋鑫.彩色多普勒超声显像在原发性胆汁性肝硬化的临床应用研究.石家庄:河北医科大学,2011.
  • 4Lindor KD, Gershwin ME, Poupon R, et al. Primary biliary cir-rhosis. Hepatology, 2009(50) :291-308.
  • 5Kovac JD, Jesic R, Stanisavljevic D, et al. Integrative role of MRIin the evaluation of primary biliary cirrhosis. Eur Radiol, 2012,22(3):688-694.
  • 6Wenzel JS, Donohoe A, Ford KL, et al. Primary biliary cirrho-sis: MR imaging findings and description of MR imaging peripor-tal halo sign. AJR Am J Roentgenol, 2001,176(4) :885-889.
  • 7Blachar A, Federle MP, Brancatelii G. Primary biliary cirrhosis:Clinical, pathologic, and helical CT findings in 53 patients. Radi-ology, 2001,220(2):329-336.
  • 8Ludwig J , Dickson E, Mcdonald GS. Staging of chronic nonsup-purative destructive cholangitis (syndrome of primary biliary cir-rhosis) .Virchows Arch A Pathol Anat Histol, 1978, 379 (2):103-112.
  • 9Selmi C, Bowlus CL, Gershwin ME, et al. Primary biliary cir-rhosis. Lancet, 2011(377) :1600-1609.
  • 10Bogdanos DP, Gershwin ME. What is new in primary biliary cir-rhosis. Dig Dis, 2012, 30(Suppl 1) : 20-31.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部